Milestone Pharmaceuticals Inc.
MIST
$1.51
-$0.13-7.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 68.36% | -10.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 58.96% | -5.60% | |||
| Operating Income | -45.89% | 5.60% | |||
| Income Before Tax | -46.02% | 8.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -46.02% | 8.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.02% | 8.05% | |||
| EBIT | -45.89% | 5.60% | |||
| EBITDA | -45.91% | 5.59% | |||
| EPS Basic | -32.85% | 36.71% | |||
| Normalized Basic EPS | -32.90% | 36.77% | |||
| EPS Diluted | -32.85% | 36.71% | |||
| Normalized Diluted EPS | -32.90% | 36.77% | |||
| Average Basic Shares Outstanding | 9.89% | 45.37% | |||
| Average Diluted Shares Outstanding | 9.89% | 45.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||